Viewing Study NCT00785668


Ignite Creation Date: 2025-12-24 @ 6:29 PM
Ignite Modification Date: 2025-12-28 @ 6:16 PM
Study NCT ID: NCT00785668
Status: COMPLETED
Last Update Posted: 2008-11-05
First Post: 2008-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects
Sponsor: Aerovance, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module